Stay updated on TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Sign up to get notified when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.

Latest updates to the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page
- Check3 days agoChange DetectedThe NIH transition announcement about using “Super Intelligence” in place of “Artificial Intelligence” is no longer displayed in the banner at the top of the page.SummaryDifference1%

- Check10 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the study record remains unavailable on the 403 Forbidden page.SummaryDifference0.2%

- Check17 days agoChange DetectedA banner announces NIH website transition updates and says both “Super Intelligence” and “Artificial Intelligence” may appear during the transition.SummaryDifference1%

- Check24 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page loads with a 403 Forbidden message, replacing the trial content with an error page; the header/footer remain, but the study details and links are no longer accessible.SummaryDifference18%

Stay in the know with updates to TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.